BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27189771)

  • 1. HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseases.
    Serrano-Villar S; Rojo D; Martínez-Martínez M; Deusch S; Vázquez-Castellanos JF; Sainz T; Vera M; Moreno S; Estrada V; Gosalbes MJ; Latorre A; Margolles A; Seifert J; Barbas C; Moya A; Ferrer M
    Sci Rep; 2016 May; 6():26192. PubMed ID: 27189771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging pathogenic links between microbiota and the gut-lung axis.
    Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM
    Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals.
    Serrano-Villar S; Rojo D; Martínez-Martínez M; Deusch S; Vázquez-Castellanos JF; Bargiela R; Sainz T; Vera M; Moreno S; Estrada V; Gosalbes MJ; Latorre A; Seifert J; Barbas C; Moya A; Ferrer M
    EBioMedicine; 2016 Jun; 8():203-216. PubMed ID: 27428431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiota and Probiotics in Health and HIV Infection.
    D'Angelo C; Reale M; Costantini E
    Nutrients; 2017 Jun; 9(6):. PubMed ID: 28621726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered gut microbiome composition in HIV infection: causes, effects and potential intervention.
    Bandera A; De Benedetto I; Bozzi G; Gori A
    Curr Opin HIV AIDS; 2018 Jan; 13(1):73-80. PubMed ID: 29045252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiome of HIV-infected people.
    Dubourg G; Surenaud M; Lévy Y; Hüe S; Raoult D
    Microb Pathog; 2017 May; 106():85-93. PubMed ID: 27216237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical communication in the gut: Effects of microbiota-generated metabolites on gastrointestinal bacterial pathogens.
    Vogt SL; Peña-Díaz J; Finlay BB
    Anaerobe; 2015 Aug; 34():106-15. PubMed ID: 25958185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health?
    Belcheva A; Irrazabal T; Martin A
    Bioessays; 2015 Apr; 37(4):403-12. PubMed ID: 25601287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiome and Obesity: A Plausible Explanation for Obesity.
    Sanmiguel C; Gupta A; Mayer EA
    Curr Obes Rep; 2015 Jun; 4(2):250-61. PubMed ID: 26029487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers.
    Vesterbacka J; Rivera J; Noyan K; Parera M; Neogi U; Calle M; Paredes R; Sönnerborg A; Noguera-Julian M; Nowak P
    Sci Rep; 2017 Jul; 7(1):6269. PubMed ID: 28740260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy.
    Li SX; Armstrong A; Neff CP; Shaffer M; Lozupone CA; Palmer BE
    Clin Pharmacol Ther; 2016 Jun; 99(6):600-11. PubMed ID: 26940481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection.
    Ross CL; Spinler JK; Savidge TC
    Anaerobe; 2016 Oct; 41():37-43. PubMed ID: 27180006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbial diversity in HIV infection post combined antiretroviral therapy: a key target for prevention of cardiovascular disease.
    El-Far M; Tremblay CL
    Curr Opin HIV AIDS; 2018 Jan; 13(1):38-44. PubMed ID: 29045253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal Androgen Exposure Causes Persistent Gut Microbiota Dysbiosis Related to Metabolic Disease in Adult Female Rats.
    Moreno-Indias I; Sánchez-Alcoholado L; Sánchez-Garrido MÁ; Martín-Núñez GM; Pérez-Jiménez F; Tena-Sempere M; Tinahones FJ; Queipo-Ortuño MI
    Endocrinology; 2016 Dec; 157(12):4888-4898. PubMed ID: 27700135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy.
    Kang Y; Cai Y
    J Hosp Infect; 2017 Aug; 96(4):342-348. PubMed ID: 28545829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calorie restriction and its impact on gut microbial composition and global metabolism.
    Zheng X; Wang S; Jia W
    Front Med; 2018 Dec; 12(6):634-644. PubMed ID: 30446879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.